Beleggen.nl
Uitgebreid zoeken
Markt MonitorMarkt Monitor

Amerikaanse aandelen Terug naar discussie overzicht

Amyris

244 Posts
Pagina: «« 1 ... 4 5 6 7 8 ... 13 »» | Laatste | Omlaag ↓
  6. forum rang 4 nb 30 april 2017 09:46

    • nb

      Lid sinds: 09 sep 2009

      Laatste bezoek: 03 mrt 2025

    • Aanbevelingen

      Ontvangen: 627

      Gegeven: 136

    •    Aantal posts: 3.753

    t zou zo maar kunnen, vandaar de recente enorme daling waarschijnlijk.
  7. forum rang 10 DeZwarteRidder 30 april 2017 10:03

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 03 mrt 2025

    • Aanbevelingen

      Ontvangen: 24411

      Gegeven: 10610

    •    Aantal posts: 102.330

    According to the complaint, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California's affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris' decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
  8. forum rang 10 DeZwarteRidder 30 april 2017 10:05

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 03 mrt 2025

    • Aanbevelingen

      Ontvangen: 24411

      Gegeven: 10610

    •    Aantal posts: 102.330

    quote:

    DeZwarteRidder schreef op 30 april 2017 10:03:

    According to the complaint, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California's affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris' decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
    Nobahamas is nu eenmaal gek op 'scam-aandelen'.

    Iedereen die hem volgt had dat kunnen weten.
  9. forum rang 10 DeZwarteRidder 30 april 2017 11:19

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 03 mrt 2025

    • Aanbevelingen

      Ontvangen: 24411

      Gegeven: 10610

    •    Aantal posts: 102.330

    PR Newswire•yesterday
    Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc.

    NEW YORK, April 28, 2017 /PRNewswire/ -- Amyris, Inc. (AMRS) Lifshitz & Miller announces investigation on behalf of AMRS investors after AMRS reported a $10 million decrease in revenue from March 2, 2017 ...
    ---------------------
    PR Newswire•2 days ago
    IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

    IRVINE, Calif., April 28, 2017 /PRNewswire/ -- Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (AMRS). Investors who purchased or otherwise acquired shares between March 2, 2017 and April 17, 2017 inclusive (the "Class Period"), are encouraged to contact the Firm in advance of the June 19, 2017 lead plaintiff motion deadline. If you purchased Amyris shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
    ---------------------------
    Accesswire•2 days ago
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amyris, Inc. - AMRS

    NEW YORK, NY / ACCESSWIRE / April 28, 2017 / Levi & Korsinsky, LLP announces it has commenced an investigation of Amyris, Inc. (NASDAQ: AMRS) concerning possible breaches of fiduciary duty. To obtain additional ...
    -----------------------
    Accesswire•2 days ago
    IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / April 27, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") ...
    ------------------------
    PR Newswire•2 days ago
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm

    NEW YORK, April 27, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amyris, Inc. ("Amyris" or the "Company") (AMRS) of the June 19, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. The lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all those who purchased Amyris securities between March 2, 2017 and April 17, 2017, (the "Class Period"). The case, OHREN v. Amyris, Inc. et al., No. 3:17-cv-02210 was filed on April 20, 2017.
    -------------------------
    Business Wire•3 days ago
    AMRS LOSS NOTICE: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important Deadline in First Filed Class Action – AMRS

    Rosen Law Firm, a global investor rights law firm, reminds purchasers of Amyris, Inc. securities from March 2, 2017 through April 17, 2017, both dates inclusive of the important June 19, 2017 lead plaintiff deadline in the first filed class action commenced by the Rosen Law Firm.
    ---------------------------
    GlobeNewswire•3 days ago
    SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Amyris, Inc. (Nasdaq: AMRS) To Contact Brower Piven Before The Lead Plaintiff Deadline

    STEVENSON, Md., April 26, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ...
    -----------------------
    Accesswire•3 days ago
    IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

    IRVINE, CA / ACCESSWIRE / April 26, 2017 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: ...
    ---------------------------
    GlobeNewswire•3 days ago
    IMPORTANT AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Amyris, Inc.

    NEW YORK, April 26, 2017-- Wolf Haldenstein Adler Freeman & Herz LLP announces that a filing class action lawsuit has been filed in the United States District Court for the Northern District of California ...
    ------------------------
    Business Wire•4 days ago
    IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

    Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Amyris, Inc. concerning possible violations of federal securities laws.
    News
    --------------------------
    Accesswire•4 days ago
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Amyris, Inc. (AMRS) and Lead Plaintiff Deadline: June 19, 2017

    NEW YORK, NY / ACCESSWIRE / April 26, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amyris, Inc. ("Amyris" or the "Company") ...
    ---------------------------
    News
    Business Wire•5 days ago
    SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Amyris, Inc.

    Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. . Investors who purchased shares between March 2, 2017 and April 17, 2017 inclusive , are encouraged to contact the firm in advance of the June 19, 2017 lead plaintiff motion deadline.
    News
    ---------------------------
    Business Wire•5 days ago
    Robbins Arroyo LLP Is Investigating the Officers and Directors of Amyris, Inc. (AMRS) on Behalf of Shareholders

    Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Amyris, Inc. violated federal securities laws by issuing materially false and misleading statements regarding the company's business and operations.
    --------------------------
    News
    Business Wire•6 days ago
    IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

    Khang & Khang LLP announces the filing of a class action lawsuit against Amyris, Inc. . Investors who purchased or otherwise acquired shares between March 2, 2017 and April 17, 2017 inclusive , are encouraged to contact the Firm in advance of the June 19, 2017 lead plaintiff motion deadline.
    ------------------------
    News
    PR Newswire•6 days ago
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Amyris, Inc. (AMRS) & Lead Plaintiff Deadline: June 19, 2017

    NEW YORK, April 24, 2017 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amyris, Inc. ("Amyris" ...
    News
    Capital Cube•6 days ago
  13. forum rang 10 DeZwarteRidder 2 mei 2017 08:23

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 03 mrt 2025

    • Aanbevelingen

      Ontvangen: 24411

      Gegeven: 10610

    •    Aantal posts: 102.330

    Amyris is een belachelijk bedrijf: bij een brutowinst van ca 3 miljoen, wordt er ca 100 miljoen uitgegeven aan research en verkoopkosten.
    Ook hebben ze ca 175 miljoen lange schuld.

    De koers is trouwens gedaald van ruim 30 USD naar ca 50 cent.
  18. forum rang 4 nb 8 mei 2017 18:54

    • nb

      Lid sinds: 09 sep 2009

      Laatste bezoek: 03 mrt 2025

    • Aanbevelingen

      Ontvangen: 627

      Gegeven: 136

    •    Aantal posts: 3.753

    dat is toch best gek, ja.
    Je kunt het bericht ook gewoon lezen op actueel of bij DSM
    ik denk een pluk aan te schaffen
  21. [verwijderd] 20 mei 2017 21:41

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Ik heb een pluk gekocht op CAD 0,33
    Er zit wel wat risico op. maar daar tegenover staat dat deze koers plotseling zomaar kan exploderen met 40 tot 80% winst.
    Nooit geschoten is altijd mis.
    Met DSM (niet de eerste de beste) heb ik toch een redelijk safe gevoel
244 Posts
Pagina: «« 1 ... 4 5 6 7 8 ... 13 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.070
AB InBev 2 5.521
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.739
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.753
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 191
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.754
Aedifica 3 917
Aegon 3.258 322.877
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.894
Agfa-Gevaert 14 2.051
Ahold 3.538 74.340
Air France - KLM 1.025 35.079
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.042
Alfen 16 24.923
Allfunds Group 4 1.478
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.357
AMG 971 133.688
AMS 3 73
Amsterdam Commodities 305 6.697
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.017
Apollo Alternative Assets 1 17
Apple 5 383
Arcadis 252 8.785
Arcelor Mittal 2.034 320.765
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.326
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.250
ASML 1.766 108.011
ASR Nederland 21 4.501
ATAI Life Sciences 1 7
Atenor Group 1 507
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.684
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.403